Relevant studies have shown that phosphorylation of the Tyr216 site of GSK-3β can promote its activation, hyperphosphorylate Tau, activate the Thr668 site of APP protein, and induce pathological changes in AD. This evidence concerns the gene APP and Alzheimer disease.